141 related articles for article (PubMed ID: 9498725)
1. 5-HT1A receptor-mediated inhibition of nucleus accumbens neurons activated by stimulation of parafascicular nucleus of thalamus.
Nagaoka I; Sasa M; Yamawaki S
Psychopharmacology (Berl); 1998 Feb; 135(3):230-5. PubMed ID: 9498725
[TBL] [Abstract][Full Text] [Related]
2. 5-HT1A receptor-mediated inhibition of lateral vestibular nucleus neurons projecting to the abducens nucleus.
Kishimoto T; Yamanaka T; Amano T; Todo N; Sasa M
Brain Res; 1994 Apr; 644(1):47-51. PubMed ID: 8032949
[TBL] [Abstract][Full Text] [Related]
3. Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens.
Amano T; Matsubayashi H; Momiyama T; Ishihara K; Todo N; Sasa M
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):105-16. PubMed ID: 7708924
[TBL] [Abstract][Full Text] [Related]
4. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
5. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
Hajós M; Hajós-Korcsok E; Sharp T
Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity of nucleus accumbens neurons to methamphetamine and dopamine following repeated administrations of methamphetamine.
Amano T; Matsubayashi H; Sasa M
Ann N Y Acad Sci; 1996 Oct; 801():136-47. PubMed ID: 8959029
[TBL] [Abstract][Full Text] [Related]
7. Ventral tegmental area-mediated inhibition of neurons of the nucleus accumbens receiving input from the parafascicular nucleus of the thalamus is mediated by dopamine D1 receptors.
Hara M; Sasa M; Takaori S
Neuropharmacology; 1989 Nov; 28(11):1203-9. PubMed ID: 2687713
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D-1 receptor-mediated inhibition of nucleus accumbens neurons from the ventral tegmental area.
Sasa M; Hara M; Takaori S
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):119-28. PubMed ID: 1826178
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of 7-OH-DPAT, dopamine D3-receptor agonist, on nucleus accumbens neurons.
Amano T; Matsubayashi H; Momiyama T; Sasa M
Jpn J Pharmacol; 1994 Jul; 65(3):293-5. PubMed ID: 7799531
[TBL] [Abstract][Full Text] [Related]
10. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
Evrard A; Laporte AM; Chastanet M; Hen R; Hamon M; Adrien J
Eur J Neurosci; 1999 Nov; 11(11):3823-31. PubMed ID: 10583471
[TBL] [Abstract][Full Text] [Related]
12. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: increase in Na+, K(+)-ATPase activity in renal proximal tubules via activation of 5-HT1A receptors.
Soares-da-Silva P; Pinto-do-O PC; Bertorello AM
Br J Pharmacol; 1996 Mar; 117(6):1199-203. PubMed ID: 8882616
[TBL] [Abstract][Full Text] [Related]
14. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
15. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Borsini F; Ceci A; Bietti G; Donetti A
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
[TBL] [Abstract][Full Text] [Related]
16. Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation.
Harte SE; Kender RG; Borszcz GS
Pain; 2005 Feb; 113(3):405-415. PubMed ID: 15661450
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997.
Hirose A; Sasa M; Akaike A; Takaori S
Neuropharmacology; 1990 Feb; 29(2):93-101. PubMed ID: 1970426
[TBL] [Abstract][Full Text] [Related]
18. Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
Grasso C; Li Volsi G; Barresi M
Arch Ital Biol; 2016 Jun; 154(2-3):39-49. PubMed ID: 27918061
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A receptors mediate the effect of the bulbospinal serotonin system on spinal dorsal horn nociceptive neurons.
Zemlan FP; Murphy AZ; Behbehani MM
Pharmacology; 1994 Jan; 48(1):1-10. PubMed ID: 8309982
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
